Investor Relations

Investor Overview

Webcast ImageWebcast
KemPharm Inc at the RBC Capital Markets 2017 Global Healthcare  (Replay)
02/22/17 at 9:00 a.m. ET
KemPharm Inc at the RBC Capital Markets 2017 Global Healthcare
Wednesday, February 22, 2017 9:00 a.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar

KemPharm uses its LAT platform technology to discover and develop prodrugs that improve one or more of the attributes of approved drugs, such as susceptibility to abuse, bioavailability and safety.

 

Stock Quote
KMPH (Common Stock)
PriceChange% ChangeVolume
$3.600.000.00%0
Previous CloseToday's OpenIntraday HighIntraday Low
$3.60$0.00$3.65$3.50
Exchange: NASDAQ (US Dollar)
02/22/17 3:59 p.m. ET
Refresh quote
Recent NewsMore >>
02/23/17
KemPharm Announces Additional Patent Protection for Prodrug Portfolio
02/07/17
KemPharm to Present at Upcoming Investor Conferences
01/09/17
KemPharm Reports Positive Data from Phase 1 Intranasal Pharmacokinetic Study of KP511, An Investigational Prodrug of Hydromorphone for the Treatment of Pain
Upcoming EventsMore >>
DateTitle
03/07/17 8:00 a.m. ET
KemPharm Inc at the Cowen & Co. 36th Annual Health Care Conference 2017
LocationThe Boston Marriott Copley Place
Boston, MA
03/12/17
through
03/15/17
KemPharm Inc at the 29th Annual ROTH Conference
LocationThe Ritz Carlton
Dana Point, CA
03/21/17 9:45 a.m. ET
KemPharm Inc at the Oppenheimer & Co. 27th Annual Healthcare Conference
LocationThe Westin New York Grand Central
New York, NY
Data provided by Nasdaq. Minimum 15 minutes delayed. View Attributions and Sources